Production (Stage)
Solid Biosciences Inc.
SLDB
$2.81
-$0.08-2.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.63% | -109.47% | -55.98% | -1.80% | 19.18% |
| Total Depreciation and Amortization | 24.46% | 129.11% | -31.12% | 11.97% | -51.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 219.41% | 470.68% | 353.02% | -16.14% | -28.88% |
| Change in Net Operating Assets | 162.82% | 184.79% | 132.46% | 101.17% | -215.36% |
| Cash from Operations | -26.43% | -42.37% | -32.47% | 21.84% | 10.01% |
| Capital Expenditure | 15.44% | -126.67% | 96.08% | 46.64% | 70.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.70% | -14.59% | 54.76% | 89.75% | -201.52% |
| Cash from Investing | 28.65% | -14.86% | 55.40% | 89.27% | -203.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.44% | 1,299.60% | -- | 110.58% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.59% | -- | -- | -- | -- |
| Cash from Financing | 76.92% | 1,274.26% | -- | 91.06% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.40% | -36.50% | 26.08% | 70.38% | 370.15% |